Dinchi Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -14.07%
(FY 2020)
- Profit 39.95%
(FY 2020)
- Ebitda 70.75%
(FY 2020)
- Net Worth -35.92%
(FY 2020)
- Total Assets 98.30%
(FY 2020)
About Dinchi Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Gupta, Vinita Agarwal, and Nitin Agarwal serve as directors at the Company.
- CIN/LLPIN
U74999PB2016PTC045603
- Company No.
045603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dinchi Pharmaceutical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Gupta  | Director | 09-Aug-2016 | Current |
| Vinita Agarwal | Director | 25-May-2021 | Current |
| Nitin Agarwal | Director | 09-Aug-2016 | Current |
Financial Performance and Corporate Structure Insights of Dinchi Pharmaceutical.
Dinchi Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.07% decrease. The company also saw a substantial improvement in profitability, with a 39.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dinchi Pharmaceutical?
In 2019, Dinchi Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Al Mualla And Aggarwal Finance LimitedActive 12 years 4 months
Vinita Agarwal and Nitin Agarwal are mutual person
- Ludhiana Kidney Hospitals LimitedActive 25 years 7 months
Vinita Agarwal and Nitin Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dinchi Pharmaceutical?
Unlock and access historical data on people associated with Dinchi Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dinchi Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dinchi Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
